Andrew Robinson

Dr Andrew Robinson serves as the Brain Bank Manager within the Division of Neuroscience at The University of Manchester. He holds a PhD in Neuroscience from the same institution (2016). His work focuses on the neuropathology of neurodegenerative diseases, particularly Alzheimer's disease and frontotemporal dementia. Key research areas include cognitive changes in aging populations, synaptic density, sleep disturbances, genetic associations like MAPT H2 haplotype studies, and epigenetic regulation in dementia.

• Education: PhD in Neuroscience from The University of Manchester (2016)

Dr Robinson's research interests emphasize identifying early biomarkers for neurodegenerative diseases through cognitive assessments and post-mortem brain analysis. He explores how subtle cognitive changes in life correlate with pathological severity at death, aiming to improve early detection and intervention strategies. His work integrates genetic studies (e.g., APOE genotyping), epigenetic analysis (season of birth effects on DNA methylation), and proteinopathy investigations (tau, TDP-43).

His scientific contributions are highlighted by the Dr Alex Carmichael Award (2016), recognizing excellence in dementia research. He collaborates internationally through the UK Brain Banks Network and BrainNet Europe, supporting over 1,000 brain samples for studies on neurodegenerative disorders. His research also touches on neuro-oncology through close ties with University of Manchester neuroscience themes.

• Grants & Advising: Manages the Manchester Brain Bank, a resource critical for dementia research. Supervised his own PhD thesis (2016) but no current advisees listed.
• Labs/Teams: Oversees the Manchester Brain Bank, a key facility for neuropathology research with 30 years of legacy in frontotemporal dementia studies.